Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global tuberculosis diagnostics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.28% during 2023-2028.
Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient’s sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.
Tuberculosis Diagnostics Market Trends:
The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tuberculosis diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease stage, test type, and end-user.
Breakup by Disease Stage:
Latent TB
Active TB
Breakup by Test Type:
Radiographic Test
Laboratory Test
Smear Microscopy
Culture-based Test
Nucleic Acid Testing
Cytokine Detection Test
Drug Resistance Test
Others
Breakup by End-User:
Hospitals and Clinics
Diagnostics and Research Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMйrieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.
Key Questions Answered in This Report:
How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global tuberculosis diagnostics market?
What is the breakup of the market based on the disease stage?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global tuberculosis diagnostics market and who are the key players?
What is the degree of competition in the industry?
The global tuberculosis diagnostics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.28% during 2023-2028.
Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient’s sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.
Tuberculosis Diagnostics Market Trends:
The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tuberculosis diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease stage, test type, and end-user.
Breakup by Disease Stage:
Latent TB
Active TB
Breakup by Test Type:
Radiographic Test
Laboratory Test
Smear Microscopy
Culture-based Test
Nucleic Acid Testing
Cytokine Detection Test
Drug Resistance Test
Others
Breakup by End-User:
Hospitals and Clinics
Diagnostics and Research Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMйrieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.
Key Questions Answered in This Report:
How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global tuberculosis diagnostics market?
What is the breakup of the market based on the disease stage?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global tuberculosis diagnostics market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 MARKET BREAKUP BY DISEASE STAGE
6.1Latent TB
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Active TB
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TEST TYPE
7.1Radiographic Test
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Laboratory Test
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Smear Microscopy
7.2.2.2 Culture-based Test
7.2.3 Market Forecast
7.3Nucleic Acid Testing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4Cytokine Detection Test
7.4.1 Market Trends
7.4.2 Market Forecast
7.5Drug Resistance Test
7.5.1 Market Trends
7.5.2 Market Forecast
7.6Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY END-USER
8.1Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Diagnostics and Research Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1Overview
12.2Bargaining Power of Buyers
12.3Bargaining Power of Suppliers
12.4Degree of Competition
12.5Threat of New Entrants
12.6Threat of Substitutes
13 PRICE INDICATORS
14 COMPETITIVE LANDSCAPE
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
14.3.1Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2Alere Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3Becton Dickinson and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4BioMйrieux
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5Cepheid Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6Epistem Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7Roche Holding AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8Hain Lifescience GmbH
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9Hologic Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10QIAGEN GmbH
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11Siemens
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 MARKET BREAKUP BY DISEASE STAGE
6.1Latent TB
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Active TB
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TEST TYPE
7.1Radiographic Test
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Laboratory Test
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Smear Microscopy
7.2.2.2 Culture-based Test
7.2.3 Market Forecast
7.3Nucleic Acid Testing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4Cytokine Detection Test
7.4.1 Market Trends
7.4.2 Market Forecast
7.5Drug Resistance Test
7.5.1 Market Trends
7.5.2 Market Forecast
7.6Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY END-USER
8.1Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Diagnostics and Research Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1Overview
12.2Bargaining Power of Buyers
12.3Bargaining Power of Suppliers
12.4Degree of Competition
12.5Threat of New Entrants
12.6Threat of Substitutes
13 PRICE INDICATORS
14 COMPETITIVE LANDSCAPE
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
14.3.1Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2Alere Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3Becton Dickinson and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4BioMйrieux
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5Cepheid Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6Epistem Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7Roche Holding AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8Hain Lifescience GmbH
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9Hologic Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10QIAGEN GmbH
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11Siemens
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Tuberculosis Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Disease Stage (in Million US$), 2023-2028
Table 3: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 4: Global: Tuberculosis Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
Table 5: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Tuberculosis Diagnostics Market: Competitive Structure
Table 7: Global: Tuberculosis Diagnostics Market: Key Players
Table 1: Global: Tuberculosis Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Disease Stage (in Million US$), 2023-2028
Table 3: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 4: Global: Tuberculosis Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
Table 5: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Tuberculosis Diagnostics Market: Competitive Structure
Table 7: Global: Tuberculosis Diagnostics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Tuberculosis Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2022
Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2022
Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2022
Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2022
Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
Figure 80: Global: Tuberculosis Diagnostics Industry: Porter’s Five Forces Analysis
Figure 1: Global: Tuberculosis Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2022
Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2022
Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2022
Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2022
Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
Figure 80: Global: Tuberculosis Diagnostics Industry: Porter’s Five Forces Analysis
